BLSMvs its industry peers
A metric-by-metric comparison of BLSM against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLSMThis | — | — | — | — | — | — | — | — | — | — | — | — |
| BGM | — | — | — | — | 51.1%#2 | -1282.1%#6 | -33.2%#3 | -5.1%#1 | — | — | -96.3%#3 | — |
| BHST | $55M#2 | — | 2.2x#1 | 1.6x#1 | 37.0%#3 | 13.8%#4 | -16.2%#2 | -43.8%#3 | -216.8%#1 | — | -69.2%#2 | — |
| BIOE | — | — | — | — | 485.8%#1 | 168.5%#1 | 47.4%#1 | — | — | 8#1 | — | — |
| BIOM | — | — | — | — | — | 16.6%#3 | — | — | — | — | — | — |
| BIXT | — | — | — | — | -22.5%#4 | 10.3%#5 | -964.3%#5 | — | — | — | — | — |
| BLRX | $7.1B#1 | — | 391.7x#2 | 6040.3x#2 | -95.9%#5 | 78.0%#2 | -871.8%#4 | -11.1%#2 | — | — | -24.8%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-09.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice